Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tanvex BioPharma Inc
Net Issuance of Common Stock Peer Comparison

Comparables:
688235
6550

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Net Issuance of Common Stock
NT$1.4B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Net Issuance of Common Stock
NT$58.3m
CAGR 3-Years
N/A
CAGR 5-Years
-37%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
1.4B TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Net Issuance of Common Stock amounts to 1.4B TWD.

What is Tanvex BioPharma Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-8%

Over the last year, the Net Issuance of Common Stock growth was 21%. The average annual Net Issuance of Common Stock growth rates for Tanvex BioPharma Inc have been -5% over the past three years , -8% over the past five years .

Back to Top